Featured Research

from universities, journals, and other organizations

Speed Of PSA Rise Helps Predict Survival For Prostate Cancer Patients

Date:
October 1, 2005
Source:
American Society for Therapeutic Radiology and Oncology
Summary:
The clinical outcome for prostate cancer patients who have been treated with hormone therapy and radiation therapy can usually be determined by how rapidly their prostate specific antigen level rises following treatment, according to a report published in the October 1, 2005 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.

The clinical outcome for prostate cancer patients who have been treatedwith hormone therapy and radiation therapy can usually be determined byhow rapidly their prostate specific antigen level rises followingtreatment, according to a report published in the October 1, 2005 issueof the International Journal of Radiation Oncology*Biology*Physics, theofficial journal of ASTRO.

Related Articles


Doctors at M.D. Anderson Cancer Center in Houston studied 621 menwith prostate cancer treated with hormone and radiation therapy between1989 and 2003 to determine whether clinical failure after theirtreatment correlated with the speed at which their post treatment PSAlevel rose. Clinical failure was defined as cancer recurring in theprostate or spreading to other parts of the body.

Researchers found that measuring how quickly the PSA leveldoubled was a good indicator of subsequent poor clinical outcomes,including cancer developing in other parts of the body or death relatedto prostate cancer.

Patients whose PSA level doubled within eight months aftertreatment failure were more likely to have the cancer return or spreadto other parts of the body than patients whose PSA did not double ineight months or less. The estimated five-year rate of clinical failurefor patients with a PSA doubling time of more than eight months wasonly 9.4 percent while 60.4 percent of patients whose PSA doubling timewas less than or equal to eight months could expect some type ofclinical failure.

"The PSA doubling time is an important indicator of how well apatient will recover from prostate cancer," said Andrew K. Lee, M.D.,lead author of the study and a radiation oncologist at M.D. AndersonCancer Center in Houston. "Although clinical outcomes may be positivelyaffected if the patient receives hormone therapy with radiationtherapy, a quickly rising PSA level unfortunately still portends poorresults for these patients."

###

For more information on radiation therapy for prostate cancer, please visit http://www.rtanswers.org.

ASTRO is the largest radiation oncology society in the world,with more than 8,000 members who specialize in treating patients withradiation therapies. As a leading organization in radiation oncology,biology and physics, the Society is dedicated to the advancement of thepractice of radiation oncology by promoting excellence in patient care,providing opportunities for educational and professional development,promoting research and disseminating research results and representingradiation oncology in a rapidly evolving socioeconomic healthcareenvironment.


Story Source:

The above story is based on materials provided by American Society for Therapeutic Radiology and Oncology. Note: Materials may be edited for content and length.


Cite This Page:

American Society for Therapeutic Radiology and Oncology. "Speed Of PSA Rise Helps Predict Survival For Prostate Cancer Patients." ScienceDaily. ScienceDaily, 1 October 2005. <www.sciencedaily.com/releases/2005/10/051001101436.htm>.
American Society for Therapeutic Radiology and Oncology. (2005, October 1). Speed Of PSA Rise Helps Predict Survival For Prostate Cancer Patients. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2005/10/051001101436.htm
American Society for Therapeutic Radiology and Oncology. "Speed Of PSA Rise Helps Predict Survival For Prostate Cancer Patients." ScienceDaily. www.sciencedaily.com/releases/2005/10/051001101436.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com
Winter Can Cause Depression — Here's How To Combat It

Winter Can Cause Depression — Here's How To Combat It

Newsy (Nov. 23, 2014) Millions of American suffer from seasonal depression every year. It can lead to adverse health effects, but there are ways to ease symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins